Navigation Links
EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference
Date:12/5/2007

TARRYTOWN, N.Y., Dec. 5 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Jack Talley, President and CEO, will present a company overview at the New York Society of Security Analysts ("NYSSA") 11th Annual Biotech & Specialty Pharma Conference on December 12, 2007 at 4:05 p.m. Eastern Time. The conference will be held at the NYSSA's headquarters at 1177 Avenue of the Americas in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

The presentation will be available live via webcast on December 12, 2007. The webcast can be accessed by visiting http://www.epicept.com. A replay of the presentation will be available for 90 days following the event.

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. The Company's broad portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead oncology compound for AML with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound is approaching a decision in Europe. In addition, EpiCept's ASAP technology, a proprietary live cell high- throughput caspase-3 screening technology, can efficiently identify new cancer drug candidates and molecular targets that selectively induce apoptosis in cancer cells. Two oncology drug candidates currently in clinical development that were discovered using this technology have also been shown to act as vascular disruption agents in a variety of solid tumors.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. EpiCept Corporation to Present at the 2007 BIO InvestorForum
2. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
3. EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007
5. EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
6. EpiCept Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
7. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
8. EpiCept Announces Presentation of New Ceplene(TM) Data at the 49th Annual Meeting of the American Society of Hematology
9. EpiCept Corporation Announces Pricing of Public Offering
10. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
11. Brooke Franchise Corporation Announces Selected July Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...tay on, tabs still end up being swallowed, study f...) -- Tabs on beverage cans -- the kind that stay a...r to children, who can swallow the tabs and damage..., About three decades ago, beverage makers star...l-tabs, which were believed to pose a swallowing h...
(Date:11/30/2009)... ShowMyPC has released an online service that... anywhere. This is the first hosted service in the...esktop program. Result, blazing fast performance e... Santa Clara, CA (PRWEB) November 30, 2009 --...mote Access Service that uses the familiar Microso...
(Date:11/30/2009)... Firm uses Staten Island courtroom to recreat...s were 100% responsible for client’s acciden...s) November 30, 2009 -- A Staten Island, N.Y. jury... paperhanger who was injured at a New York City co...v. J.T. Magen Construction Company et al (Index No...
(Date:11/30/2009)...EVELAND, Ohio, November 30 Simbion...of medical simulation systems, in collaboration,wi...ure Rehearsal Studio(TM),workshop for the first ti...any. , The Simbionix PROcedure Rehearsal ...to enable clinicians to create practice scenarios ...
(Date:11/30/2009)...phy is an effective, convenient technique that, wh...ancerous breast lesions from benign results, accor...nual meeting of the Radiological Society of North ...ious findings, physicians often use ultrasound to ... has the potential to result in more biopsies beca...
Breaking Medicine News(10 mins):Health News:Beverage Can Tabs Remain a Risk for Kids 2Health News:ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop 2Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Elastography reduces unnecessary breast biopsies 2
...New designation defines a material,s ecological in...process of designing safe, sustainable products ,... Braungart Design Chemistry, LLC), a consultancy f...certification, which assesses the sustainability o...
...OVERLAND PARK, Kan., Jan. 28 Swiss Re,s Employer...s to the growing number of companies interested in...nited States. The coverage enables employers to c...d the District of Columbia through Westport Insura...
...SHAWNEE, Kan., Jan. 28 With 27 years of experienc...rbara Gail Kimberlin-Murphy reveals the behind-the...iction guidebook, "Secrets Revealed By A Medical C...tient and medical community with the top 10 secret...
...MELVILLE, N.Y., Jan. 28 Gentiva Health Services...mprehensive home health services, announced today ...st on Wednesday, February 18, 2009, at 10:00 a.m. ...morning of February 18 before pre-market trading. ...
... SAN FRANCISCO, Jan. 28 The Glaucoma Research ...it this evening in San Francisco. This,annual even...s the showcase,for recent advances in GRF-funded r...s Catalyst for a,Cure (CFC) consortium. A receptio...
...New Survey Shows Parents and Caregivers are Uninfo...dly Snacks , , CHICAGO, Jan. 28 According to a r...Dentistry (AAPD), the recognized leader in childre...hildren,s risk of developing cavities. , , To vi...
Other Medicine News:Health News:Cradle to Cradle(SM) Digs Beneath the Surface with New Ingredient Certification 2Health News:Cradle to Cradle(SM) Digs Beneath the Surface with New Ingredient Certification 3Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 2Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 3Health News:'Secrets Revealed By A Medical Collector, The Patient's Guide to Avoiding Bankruptcy' 2Health News:'Secrets Revealed By A Medical Collector, The Patient's Guide to Avoiding Bankruptcy' 3Health News:Gentiva(R) Health Services Schedules Fourth Quarter and Fiscal 2008 Earnings Call and Web Cast for Wednesday, February 18, 2009 2Health News:Gentiva(R) Health Services Schedules Fourth Quarter and Fiscal 2008 Earnings Call and Web Cast for Wednesday, February 18, 2009 3Health News:Glaucoma Research Foundation to Hold Annual Fundraising Benefit 2Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 2Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 3Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 4
(Date:11/29/2009)...CAGO, Nov. 30 A large proportion o...omography (CT) receive unindicated and unnecessary... avoidable radiation exposure, according to a stud...iological Society of North America (RSNA). ,, "...k with ionizing radiation to ensure that the dosag...
(Date:11/29/2009)...IOWA CITY, Iowa and ST. LOUIS, Nov. 29 /PRNewswire...titative imaging software for the advanced analysi...ogies, a leader in minimally invasive delivery of ...ompanies have signed a definitive agreement coveri...onchial lung navigation and biopsy system. ,, ...
(Date:11/29/2009)...CAGO, Nov. 29 This year at the Rad...ic Assembly and Annual Meeting, FUJIFILM Medical S...anced visualization space with the introduction of...e strength in image processing by now offering its...l radiographic and cardiovascular applications. T...
Breaking Medicine Technology:Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM Enters Advanced Visualization Market 2FUJIFILM Enters Advanced Visualization Market 3FUJIFILM Enters Advanced Visualization Market 4Demi Lovato Joins National Bullying Prevention Movement 53681 1Demi Lovato Joins National Bullying Prevention Movement 53681 2Abnormal Brain Circuits May Prevent Movement Disorder 53678 1Abnormal Brain Circuits May Prevent Movement Disorder 53678 2Abnormal Brain Circuits May Prevent Movement Disorder 53678 3Abnormal Brain Circuits May Prevent Movement Disorder 53678 4Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient 13365 1Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient 13365 2
...gnificant Improvements With ROX-828 In Migraine Pa...s Vs. Placebo, MENLO PARK, Calif., April 28 ROXR...ata from a clinical study of the company,s,novel i...atment of migraine,and related symptoms., The pla...he efficacy,and safety of ROX-828, an intranasal f...
... IIa Efficacy Results, LAUSANNE, Switzerland, Apr...ependent biopharmaceutical development specialist,...ly oncology, presented,positive efficacy results o...clophilin (Cyp) inhibitor with a potent in-vitro a...icates that Debio 025 shows an,important additive ...
Other Medicine Technology:ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 3Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: